InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: thefamilyman post# 3439

Friday, 08/31/2018 9:41:13 AM

Friday, August 31, 2018 9:41:13 AM

Post# of 3831
Actually Yeryov is different than Opdivo.

Y attack different than Ketruda in MOA and Opdivo is PD-1 much direct competition to Ketruda.

So BMY can buy GALT - start trials with O, go with NASH. Then decide whether to share GRMD02 with Merck and allow them to increase ORR or share revenue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News